Atıf Formatları
QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

I. YILMAZ Et Al. , "QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands," 7th International BAU Drug Design Congress , İstanbul, Turkey, pp.67, 2019

YILMAZ, I. Et Al. 2019. QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands. 7th International BAU Drug Design Congress , (İstanbul, Turkey), 67.

YILMAZ, I., AKYOL, S. F., KAYNAR, E., & EROĞLU, E., (2019). QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands . 7th International BAU Drug Design Congress (pp.67). İstanbul, Turkey

YILMAZ, Ipek Et Al. "QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands," 7th International BAU Drug Design Congress, İstanbul, Turkey, 2019

YILMAZ, Ipek Et Al. "QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands." 7th International BAU Drug Design Congress , İstanbul, Turkey, pp.67, 2019

YILMAZ, I. Et Al. (2019) . "QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands." 7th International BAU Drug Design Congress , İstanbul, Turkey, p.67.

@conferencepaper{conferencepaper, author={Ipek YILMAZ Et Al. }, title={QSAR, Molecular Docking and Design Study of Phenylalkylamines as 5-HT2A Receptor Aganist Ligands}, congress name={7th International BAU Drug Design Congress}, city={İstanbul}, country={Turkey}, year={2019}, pages={67} }